Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2026 11:23 ET | Source: Research and Markets

Electrocardiograph Market Insights and Growth Outlook 2026-2034 - Rising Adoption of Wearable ECGs Spurs Market Growth in Medical Tech

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Electrocardiograph Market Size, Share, Trends and Forecast by Product, Lead Type, End User, and Region, 2026-2034" has been added to ...
April 20, 2026 11:12 ET | Source: Precedence Research

Chemical Intermediate Market Size Worth USD 547.69 Billion by 2035

The chemical intermediate market is projected to grow from USD 328.34 billion in 2026 to USD 547.69 billion by 2035, at a CAGR of 5.85% during the forecast
April 20, 2026 09:28 ET | Source: Research and Markets

Dry Room Dehumidifier Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2021-2031

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Dry Room Dehumidifier Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
April 20, 2026 09:00 ET | Source: Portnoy Law

Instil Bio, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 20, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Instil Bio, Inc., (“Instil" or the "Company") (NASDAQ: TIL) investors that the firm has initiated an investigation into...
April 20, 2026 07:30 ET | Source: Biogen Inc.

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one ownerAdvancing felzartamab – a CD38-directed...
April 20, 2026 07:00 ET | Source: Sagimet Biosciences Inc.

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

SAN MATEO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional...
April 17, 2026 16:49 ET | Source: Boundless Bio, Inc.

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting

SAN DIEGO, April 17, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies...
April 16, 2026 07:59 ET | Source: BIO-key International, Inc.

BIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the Period

BIO-key previewed its business outlook for first half 2026. The company expects a 50% Increase in first half revenues, driving positive profitability.
April 16, 2026 06:13 ET | Source: Research and Markets

Analysis of the Booming Smart Waste Management Market, 2026-2030 - Integration of IoT and Smart City Infrastructure Driving Industry Growth

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Smart Waste Management Market 2026-2030" has been added to ResearchAndMarkets.com's offering. The global smart waste management market is...
April 16, 2026 05:07 ET | Source: Research and Markets

Future Markets Research Service: Online Access to 200+ Market Reports on Advanced and Emerging Technologies, Market Analysis, Mapping, Company Data, Product Developments, and Latest Trends

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Future Markets Annual Subscription" subscription has been added to ResearchAndMarkets.com's offering. Advanced materials have the potential to...